אירסה - Iressa

×©××× ××Â !
××ª××¨××: 22.5.2022 ××ª×§××× ××××¢× ×× ×©××××§ ××ª×¨××¤× ×××¤×¡×§ ××¦×××ª××ª.

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)

L01EB
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

××¨××× ×¤×¢×× (ATC5)

Gefitinib 250MG âL01EB01

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

××××××ª ××¦××¤××ª ×¤×××, FILM COATED TABLETS
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Iressa is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

03/01/2010

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××¡×¨×× ×¨××× ××ª×§×× ××§××× ×× ××¨××¨×ª× ××¡×× non small cell	01/03/2010

×©××××© ××¡×

××¡××¨×ª ××××× ××¡×

1. ××ª×¨××¤× ×ª×× ×ª× ××××¤×× ×××§×¨×× ××××:

×. ×¡×¨×× ×¨××× ××ª×§×× ××§××× ×× ××¨××¨×ª× ××¡×× non small cell, ××××¨ ××©× ××××¤×× ×§××× ××ª×¨××¤× ×××¨×ª ×××××¢××ª ×××ª×××× ××, ××§× ×××¤×× ×©× × ×× ×©×××©×;

2. ×§××× ××××× ×××¤×× ××××ª ×××ª×¨××¤××ª Erlotinib ×× Gefitinib ×× Afatinib, ×× ××§×× ×××¤×× ××ª×¨××¤× ××××¨×ª, ×××ª×××× ××;

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 06.05.2021

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 06.05.2021 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 30.11.2018 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 30.11.2018

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××¨×¡× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	ASTRA ZENECA UK LIMITED
×©× ××¢× ××¨××©××	ASTRA ZENECA (ISRAEL) LTD
×¨××©×××	×ª××¨×× ×××©×: 09/2003. ×¨××©××× ××ª××¨××: 07/2015
×ª××¨×× ×¢×××× ×××¨××	22.5.2022

השינוי האחרון נעשה בֹ־27 בפברואר 2024 ב־07:48

אירסה - Iressa

ויקיתרופות